Condition: Severe Malaria · Severe Anemia · Sponsor: Liverpool School of Tropical Medicine
The goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with dihydroartemisinin-piperaquine in the post-discharge management of children hospitalised with severe anaemia or severe malaria to optimise adherence in Kenya. The actual interventions to be evaluated have been co-designed with national stakeholders during an initial formative research stage.
This description comes directly from the study's public registry record.
Jenny Hill, MSc, PhD · +44 7732 161 353 · jenny.hill@lstmed.ac.uk
Juliet Otieno, MD, PhD · +254 721432548 · Juliet.Otieno@lstmed.ac.uk
Always discuss trial participation with your own doctor first.
| Kemri, Cghr | Kisumu, Kenya | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06624631